Nefazodone → Nefazodone hydrochloride

HRID 1758915

Reaktionsgleichung

Reaktionsgleichung von HRID 1758915
[Na].O(CCBr)C1C=CC=CC=1.[Cl:12][C:13]1[CH:14]=[C:15]([N:19]2[CH2:24][CH2:23][N:22]([CH2:25][CH2:26][CH2:27][N:28]3[C:32](=[O:33])[N:31]([CH2:34][CH2:35][O:36][C:37]4[CH:42]=[CH:41][CH:40]=[CH:39][CH:38]=4)[C:30]([CH2:43][CH3:44])=[N:29]3)[CH2:21][CH2:20]2)[CH:16]=[CH:17][CH:18]=1>C1(C)C(C)=CC=CC=1>[ClH:12].[Cl:12][C:13]1[CH:14]=[C:15]([N:19]2[CH2:20][CH2:21][N:22]([CH2:25][CH2:26][CH2:27][N:28]3[C:32](=[O:33])[N:31]([CH2:34][CH2:35][O:36][C:37]4[CH:42]=[CH:41][CH:40]=[CH:39][CH:38]=4)[C:30]([CH2:43][CH3:44])=[N:29]3)[CH2:23][CH2:24]2)[CH:16]=[CH:17][CH:18]=1

Komponenten

5

Edukt 3

HCID 4449NefazodoneHCID 68526Benzene, (2-bromoethoxy)-HCID 5360545Sodium

Produkt 1

HCID 54911Nefazodone hydrochlorideAusbeute 30,7 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 7237O-XyleneLösungsmittel2×

Versuchsvorschrift

The sodium salt is pulverized, suspended in 200 ml. of xylene and mixed with phenoxyethyl bromide (10.4 g., 0.052 mole) in 20 ml. of xylene. The resulting mixture is refluxed with stirring for a 64 hr. period and the hot reaction mixture filtered. The filtrate is concentrated under reduced pressure and residual material taken up in ether. Insolubles are collected and the ether filtrate concentrated to afford 22.9 g. (94%) of 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxyethyl)-2H-1,2,4-triazol-3(4H)-one as the free base. Purification of the product is carried out by acidifying a solution of the free base in ethanol with ethanolic hydrogen chloride, and crystallization to afford hydrated (0.25 mole) 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-4-(2-phenoxyethyl)-2H-1,2,4-triazol-3(4H)-one hydrochloride, m.p. 175°-177° C. (30.7% yield).

Aufarbeitung

  1. temperatureThe resulting mixture is refluxed
  2. filtrationperiod and the hot reaction mixture filtered
  3. concentrationThe filtrate is concentrated under reduced pressure and residual material
  4. customInsolubles are collected
  5. concentrationthe ether filtrate concentrated
  6. customto afford 22.9 g
  7. customPurification of the product
  8. customwith ethanolic hydrogen chloride, and crystallization

Quellen und Nachweise

ORD-Eintrag
ord-c1bd14cd830d4878a974d498d8b07cc5
Quelldatensatz
uspto-grants-1982_07
Patentnummer
US04338317

Verknüpfte Notizen

Wird geladen…